Retraction notice to “miR-522-3p Promotes Tumorigenesis in  Human Colorectal Cancer via Targeting Bloom Syndrome Protein”  [Oncology Research 26(7) (2018) 1113–1121]

Feng Shuai; Bo Wang; Shuxiao Dong

doi:10.3727/096504021X16297183140281

Open Access

RETRACTION

Retraction notice to “miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein” [Oncology Research 26(7) (2018) 1113–1121]

Feng Shuai^*, Bo Wang^†, Shuxiao Dong^‡

* Department of Gastroenterology, Eastern District of Linyi People’s Hospital, Linyi, Shandong, P.R. China
† Department of Pediatrics, Chinese Medicine Hospital in Linyi City, Linyi, Shandong, P.R. China
‡ Department of Gastrointestinal Surgery, Linyi People’s Hospital, Linyi, Shandong, P.R. China

Oncology Research 2020, 28(9), 977-977. https://doi.org/10.3727/096504021X16297183140281

Download PDF

Abstract

This article has no abstract.

Cite This Article

Shuai, F., Wang, B., Dong, S. (2020). Retraction notice to “miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein” [Oncology Research 26(7) (2018) 1113–1121]. Oncology Research, 28(9), 977–977.

BibTex EndNote RIS

This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Table of Content

Retraction notice to “miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein” [Oncology Research 26(7) (2018) 1113–1121]

Abstract

Cite This Article

256

146

0

Further Information

Guidelines

Contact Us

Share Link